C2i Genomics vs Novasight
C2i Genomics vs Novasight, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: C2i Genomics is on 62/100 and Novasight on 54/100.
Where each one leads
C2i Genomics
- our overall score: 62/100 against 54/100
- domain rating: 63/100 against 42/100
- funding raised: $112M against $8.0M
- LinkedIn following: 6,366 against 5,019
Novasight
- agent readiness: 50/100 against 30/100
- headcount growth: -10.2% against -20.8%
At a glance
| Measure | C2i Genomics | Novasight |
|---|---|---|
| What it is | Comprehensive whole-genome monitoring for cancer recurrence and progression. | AI and eye-tracking platform for early detection and treatment of pediatric vision loss. |
| Category | Healthcare, Genomics, Cancer, Tumor Detection | Healthcare, Optometry, Eye Tracking, HealthTech |
| Sells toBusiness model | B2B | B2B, B2C |
| Offering | Software | Software |
| Founded | 2018 | 2016 |
| Headquarters | Tel Aviv, Israel | Tel Aviv, Israel |
| Status | Active | Inactive |
Size, funding and growth
| Measure | C2i Genomics | Novasight |
|---|---|---|
| Employees | 17 | 17 |
| Headcount growthLast 12 months | -20.8% | -10.2% |
| Total funding | $112M | $8.0M |
| Latest round | Series B | Series A |
| LinkedIn followers | 6,366 | 5,019 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | C2i Genomics | Novasight |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 54/100 |
| Traction | 53/100 | 47/100 |
| Team | 90/100 | 60/100 |
| Search visibility | 35/100 | 34/100 |
| Quality | 65/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (30/100) | D (50/100) |
| Domain ratingLink authority, 0-100 | 63/100 | 42/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | C2i Genomics | Novasight |
|---|---|---|
| Hosting | Not detected | Google Cloud |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery, Bootstrap | Not detected |
| Analytics | Google Analytics 4, Google Tag Manager | Not detected |
C2i Genomics vs Novasight: common questions
Which is better, C2i Genomics or Novasight?
On our 0-100 score C2i Genomics rates higher (62/100 against 54/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do C2i Genomics and Novasight compare on the numbers?
C2i Genomics leads on our overall score (62/100 against 54/100), domain rating (63/100 against 42/100), funding raised ($112M against $8.0M), LinkedIn following (6,366 against 5,019). Novasight leads on agent readiness (50/100 against 30/100), headcount growth (-10.2% against -20.8%).
Read the full C2i Genomics review and pricing or the Novasight review and pricing. You can also browse other C2i Genomics alternatives we track.